The reduction in U.S.-China tariffs is good news for investors, but looming tariffs on pharmaceutical and tech products could still delay many big spending plans. “A key question in our mind is whethe …
Is Today’s Tariff Rollback Enough for Companies to Feel Comfortable Investing?
view original post